Tumor Board Review utilizes the knowledge and expertise of oncology specialists to enhance learning the practice of oncology. Each of the 32 chapters follows a uniform format: a concise summary of the epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of the relevant staging (generally based on the American Joint Commission on Cancer [AJCC] Staging, 7th Edition); and several Ïtumor boardÒstyleÓ illustrative patient case summaries (representative of major stage categories of each tumor), each followed by an evidence-based case discussion which reviews the current guidelines and rationale for the diagnostic and therapeutic steps taken. Algorithms and decision tree graphics are used extensively to provide visual support of the decision process.
The combination of case presentations and evidence-based management discussions make this volume a unique tool for keeping current with clinical guidelines and provides the reader with a clear understanding of applications of new information for use in daily practice. The case presentations and authoritative discussions make Tumor Board Review a valuable resource for board study and self-assessment. Features of Tumor Board Review Include:
- Comprehensive coverage of all areas of oncology
- Presentation of most recent guidelines and management standards in concise, user-friendly format
- In-depth ‘tumor board’ presentations showing clear clinical applications
- Special focus on indications and use of new drugs, and treatment of new side effects
- Extensive use of algorithms
- Color atlas section of pathology photomicrographs
Table des matières
Preface, Contributors, 1. Head and Neck Cancer,
Irina Y. Dobrosotskaya and
Francis P. Worden 2. Thyroid Cancer,
Kevin Mc Donnell and
Megan Rist Haymart 3. Non-Small Cell Lung Cancer,
Kathleen E. Bickel, Baskaram Sundaram, Stuart M. Knoepp, Collette M. Hodges, and
Nithya Ramnath 4. Small Cell Lung Cancer,
Igor I. Rybkin and
Gregory P. Kalemkerian 5. Breast Cancer,
Aihua Edward Yen, Michelina M. Cairo, and
Mothaffar F. Rimawi 6. Esophageal Cancer,
David Shepard and
Susan Urba 7. Gastric Cancer,
Eduardo Vilar and
Mark M. Zalupski 8. Pancreatic Cancer,
Ahmed A. Eid and
Dongxin Liu 9. Neuroendocrine Tumors,
Mariela Blum and
Garrett R. Lynch 10. Hepatobiliary Cancers,
Ahmed Awais and
Paul Zhang 11. Colorectal Cancer,
Yvonne Sada and
Benjamin Musher 12. Anal Canal Carcinoma,
Muhammad Anas Tarakji and
Elizabeth Yu Chiao 13. Prostate Cancer,
Jingsong Zhang, Kathleen A. Cooney, and
Maha H. Hussain 14. Testicular Carcinoma,
Diego Bedoya and
Martha Pritchett Mims 15. Kidney Cancer,
Jenny J. Kim and
Bruce G. Redman 16. Bladder Cancer,
Colin J. Mooney and
David C. Smith 17. Cervical Cancer,
Shan Guo, Marian Yvette Williams-Brown, and
Concepcion R. Diaz-Arrasti 18. Uterine Cancer,
Atisha Manhas and
Matthew L. Anderson 19. Ovarian Cancer,
Karen Mc Lean and
Ronald J. Buckanovich 20. Melanoma,
Kevin Mc Donnell and
Christopher D. Lao 21. Bone Sarcoma,
Vera Maranci and
Scott M. Schuetze 22. Soft Tissue Sarcoma,
Dawit Aregawi and
Rashmi Chugh 23. Primary Brain Tumors,
Janet Wang and
Pamela New 24. Cancer of Unknown Primary,
Yuval Raizen and
Gerald S. Cyprus 25. Hodgkin Lymphoma,
Polly Niravath and
Catherine M. Bollard 26. Non-Hodgkin Lymphoma,
Michelina Cairo, A. Edward Yen, and
Helen E. Heslop 27. Multiple Myeloma,
Kevin Mc Donnell and
Andrzej J. Jakubowiak 28. Acute Lymphoblastic Leukemia,
Naval G. Daver and
Mark M. Udden 29. Acute Myelogenous Leukemia,
Mohsen Arani and
Sarvari V. Yellapragada 30. Chronic Myeloid Leukemia,
Rami Khoriaty and
Moshe Talpaz 31. Chronic Lymphocytic Leukemia,
Rami Khoriaty and
Sami N. Malek 32. Myelodysplastic Syndrome,
John Magenau and
Dale Bixby, Index
A propos de l’auteur
Francis P. Worden, MD is a Professor of Medicine and Director of the Hematology/Oncology Fellowship Program at the University of Michigan Medical School in Ann Arbor, Michigan.